Ottawa, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The global human growth hormone injection market size is calculated at USD 4.82 billion in 2026 and is expected to reach around USD 8.54 billion by 2035, ...

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya (R) (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...

Global Human Growth Hormone (HGH) Market · GlobeNewswire Inc. Dublin, Jan. 07, 2026 (GLOBE NEWSWIRE) -- The "Human Growth Hormone (HGH) Market Report by Application, Distribution Channel, Route of ...

Somapacitan, a long-acting human growth hormone analog, was evaluated in growth hormone treatment-naïve, pre-pubertal pediatric patients.

Human growth hormone (hGH) is linked to muscle mass, weight loss, and increased athletic performance. You produce hGH naturally, but you can also get injections of recombinant growth hormone (rhGH).

Pfizer disclosed the regulatory action late Friday. FDA complete response letters are not public documents, and the company did not say what concerns or questions were raised by the agency about the ...

There are now many recombinant human growth hormone (rhGH) products and delivery devices available for rhGH therapy. Not all products are approved to treat both children and adults, and they vary with ...

Five years ago, Cass Almendral, a 56-year-old New Yorker who runs a consulting business, started injecting himself with synthetic human growth hormone (HGH) — and drastically changed his aging body.